FDA PMA
FDA Class 3
30-Day Notice Accepted
🇺🇸 United States
Intracranial Aneurysm Flow Diverter
PMA: P180027
·
Supplement: S007
·
Decision Mar 1, 2022
Classifications
1
FEI Numbers
11
Registration Numbers
11
Basic Information
- Device Name
- Intracranial Aneurysm Flow Diverter
- Trade Name
- Flow Re-Direction Endoluminal Device (FRED®) System, FREDX System
- PMA Number
- P180027
- Supplement Number
- S007
- Device Class
- FDA Class 3
- Product Code
- OUT
- Generic Name
- Intracranial aneurysm flow diverter
- Medical Specialty
- Unknown
- Advisory Committee
- Neurology
- Decision
- 30-Day Notice Accepted
- Decision Code
- OK30
- Decision Date
- March 1, 2022
- Date Received
- January 31, 2022
- Supplement Type
- 30-Day Notice
- Supplement Reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Expedited Review
- N
Advisory Committee Statement
Relocation of the supplier of several Flow Re-Direction Endoluminal Device (FRED) System and FRED X System components, Creganna Medical, from the manufacturing location in Tualatin, Oregon, to Wilsonville, Oregon, and Heredia, Costa Rica.
Classifications
This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| OUT | Intracranial Aneurysm Flow Diverter | FDA class 3 | Unknown |